Whole Genome Sequencing vs SNP Genotyping: Which DNA Test Should You Choose?

If you have been researching DNA testing in India, you have likely encountered two terms repeatedly: SNP genotyping and whole genome sequencing (WGS). Both technologies read your DNA, but they do so in fundamentally different ways, at vastly different price points, and with distinct strengths and limitations. Choosing between them is one of the most important decisions you will make when ordering a DNA test - and the right answer depends entirely on what you want to learn.

This guide provides a thorough, technically grounded comparison of these two DNA testing approaches. We will cover exactly how each technology works, what it costs in India, what it can and cannot tell you, how the data differs, and which scenarios call for which test. By the end, you will have the clarity to make a confident, informed decision.

What Is SNP Genotyping?

SNP genotyping (also called microarray genotyping or DNA chip testing) is the technology behind virtually all consumer DNA tests on the market today - from Helixline and 23andMe to AncestryDNA and MyHeritage. It works by checking specific, pre-selected positions in your genome where humans are known to differ.

How It Works

A SNP (single nucleotide polymorphism, pronounced "snip") is a single-letter variation in the DNA code. At certain positions across the genome, different people carry different nucleotide letters - for example, some people have an A at a particular position while others have a G. There are approximately 10 million such common variation points in the human genome.

SNP genotyping uses a DNA microarray - a glass chip roughly the size of a postage stamp, onto which millions of microscopic DNA probes have been deposited in a precise grid. Each probe is a short, synthetic strand of DNA designed to bind to the region surrounding a specific SNP. Here is the step-by-step process:

1. DNA extraction: DNA is isolated from your saliva sample using chemical processes that break open cells and purify the genetic material
2. Amplification and fragmentation: The extracted DNA is copied thousands of times via whole-genome amplification and then fragmented into short pieces (200-500 base pairs)
3. Hybridization: The single-stranded DNA fragments are washed over the microarray chip. Through complementary base pairing (A binds to T, C binds to G), each fragment binds to its matching probe on the chip. This step takes 16-24 hours
4. Fluorescent detection: Fluorescently labelled nucleotides are added at each SNP position. Different alleles generate different coloured signals - for example, allele A might fluoresce red while allele B fluoresces green
5. Scanning and genotype calling: A high-resolution laser scanner reads the fluorescence at each probe location. Algorithms then assign a genotype (AA, AB, or BB) at each SNP based on signal intensity and colour

The most widely used platform is the Illumina Global Screening Array (GSA), which tests approximately 700,000 SNPs in a single run. Helixline uses this platform with custom content optimized for South Asian genetics, including ancestry-informative markers specific to Indian subcontinent populations.

What Genotyping Covers

• Ancestry-informative markers (AIMs): Thousands of SNPs chosen because they differentiate ancestral populations, enabling precise ethnicity estimates across 75+ South Asian regions on Helixline
• Pharmacogenomic variants: SNPs in drug-metabolising enzymes (CYP2D6, CYP2C19, VKORC1) that predict how you respond to medications
• Known disease-risk variants: Common SNPs with established associations to conditions like type 2 diabetes, coronary artery disease, and celiac disease
• Carrier screening markers: Variants for recessive conditions including beta-thalassemia, sickle cell disease, and cystic fibrosis
• Haplogroup markers: Mitochondrial DNA (maternal lineage) and Y-chromosome (paternal lineage) SNPs for deep ancestral origin tracing
• Trait-associated SNPs: Variants linked to physical traits like lactose tolerance, caffeine metabolism, and skin pigmentation

What Is Whole Genome Sequencing?

Whole genome sequencing (WGS) takes a fundamentally different approach: instead of checking pre-selected positions, it reads every single base pair in your genome - all 3.2 billion of them. This provides a complete, unbiased picture of your genetic code.

How It Works

WGS uses a technology called sequencing by synthesis (on Illumina platforms, the most common) or nanopore sequencing (on Oxford Nanopore platforms). Here is the process:

1. DNA extraction: Same as genotyping - DNA is isolated from your sample
2. Library preparation: The DNA is fragmented into short pieces (typically 300-500 base pairs for Illumina), and adaptor sequences are attached to each end. These adaptors allow the fragments to attach to the sequencing flow cell and serve as primers for the sequencing reaction
3. Cluster generation: DNA fragments are loaded onto a glass flow cell, where each fragment is amplified into a cluster of identical copies. Millions of clusters form across the flow cell surface
4. Sequencing by synthesis: Fluorescently labelled nucleotides are flowed across the flow cell one at a time. As each nucleotide is incorporated into the growing DNA strand, it emits a specific colour of light. A camera captures the colour at each cluster position in every cycle, building up the sequence letter by letter. A typical run performs 150 cycles, reading 150 base pairs from each end of every fragment (called paired-end 2x150 reads)
5. Alignment and variant calling: Billions of short sequence reads are computationally aligned to the human reference genome (GRCh38). Sophisticated algorithms then identify every position where your DNA differs from the reference - these are your genetic variants

Understanding Coverage Depth

A critical concept in WGS is coverage depth, expressed as a number followed by "x" (e.g., 30x). This indicates how many times, on average, each base pair in the genome has been read. At 30x coverage - the standard for clinical-grade sequencing - every position is read approximately 30 times. This redundancy is essential for distinguishing true genetic variants from random sequencing errors. Lower coverage (15x or even 0.4x "low-pass" sequencing) is cheaper but less accurate, particularly for detecting heterozygous variants where only one of your two chromosome copies carries the variant.

What WGS Covers

• All common variants: Everything a genotyping array would detect, plus millions more
• Rare and novel variants: Mutations found in fewer than 1% of the population, including family-specific and de novo mutations
• Structural variants: Large insertions, deletions, duplications, inversions, and copy number variations (CNVs) ranging from hundreds to millions of base pairs
• Non-coding regions: Variants in regulatory regions, introns, and intergenic regions that influence gene expression but are not in protein-coding sequences
• Mitochondrial genome: Complete mitochondrial DNA sequence at very high depth, enabling detection of heteroplasmy (mixtures of mtDNA variants)
• Short tandem repeats (STRs): Repetitive sequences involved in conditions like Huntington's disease and fragile X syndrome
• Pharmacogenomic and ancestry data: All the same variants used for ancestry and drug response, plus additional context from surrounding sequence

Head-to-Head Comparison: WGS vs SNP Genotyping

The following table summarises the key differences across every major dimension that matters when choosing a DNA test:

Feature	SNP Genotyping	Whole Genome Sequencing (30x)
Technology	DNA microarray (chip-based)	Sequencing by synthesis (flow cell)
Positions read	600,000-700,000 pre-selected SNPs	All 3.2 billion base pairs
Genome coverage	~0.02% of genome (targeted)	~98%+ of genome (comprehensive)
Cost in India	Rs 5,000-15,000	Rs 15,000-50,000
Helixline pricing	Rs 6,999 (Origins kit)	Rs 17,999 (Genome kit)
Turnaround time	3-5 weeks	6-10 weeks
Raw data file size	~10-50 MB	~100-200 GB (raw); 5-10 GB (processed VCF)
Common variant detection	Excellent (for variants on the chip)	Excellent (all variants detected)
Rare variant detection	Poor (not on the chip)	Excellent
Structural variant detection	Very limited	Good (with sufficient coverage)
De novo mutation detection	Not possible	Yes (especially with trio analysis)
Ancestry analysis	Excellent (arrays optimised for AIMs)	Excellent (all AIMs present in data)
Pharmacogenomics	Good (common PGx variants)	Comprehensive (including rare PGx variants)
Re-analysis potential	Limited to variants on the chip	Unlimited - entire genome available for future re-analysis
Computational requirements	Low (standard laptop can handle data)	High (requires bioinformatics pipeline, significant storage)
Best for	Ancestry, wellness, carrier screening, common traits	Rare disease diagnosis, research, comprehensive health analysis

Cost Comparison in India

Price is often the deciding factor for DNA test buyers in India. Here is a realistic breakdown of what each technology costs as of 2026:

SNP Genotyping Costs

Consumer genotyping tests in India range from Rs 5,000 to Rs 15,000. The raw chip cost for an Illumina GSA is relatively low per sample (especially when run in batches of 24 on a single BeadChip), which is why consumer DNA companies can offer affordable pricing. Helixline's Origins ancestry kit is priced at Rs 6,999 and includes SNP genotyping on the Illumina GSA with full ancestry analysis across 75+ South Asian regions, haplogroups, and genetic insights.

Whole Genome Sequencing Costs

WGS in India typically costs Rs 15,000 to Rs 50,000 depending on coverage depth, whether clinical interpretation is included, and the laboratory's accreditation level. A standard 30x WGS without interpretation runs Rs 15,000-25,000, while clinical-grade WGS with variant interpretation from NABL-accredited labs can exceed Rs 40,000. Helixline's Genome tier offers 30x whole genome sequencing at Rs 17,999, combining comprehensive sequencing with ancestry and health analysis powered by Helixline's South Asian-optimised algorithms.

Cost Per Data Point

An interesting way to compare value is cost per genetic variant detected. Genotyping at Rs 6,999 for ~700,000 SNPs works out to roughly Rs 0.01 per variant. WGS at Rs 17,999 for ~4-5 million variants works out to roughly Rs 0.004 per variant - technically cheaper per data point, but only if you actually need all that data. For most ancestry and wellness applications, the 700,000 genotyped SNPs provide more than sufficient resolution.

Accuracy: How Reliable Is Each Technology?

Both SNP genotyping and WGS are highly accurate technologies when performed properly, but they differ in how and where errors can occur.

SNP Genotyping Accuracy

Modern Illumina microarrays achieve a concordance rate exceeding 99.9% for common SNPs - meaning that if you were genotyped twice, 699,300 out of 700,000 SNPs would give identical results. The call rate (percentage of SNPs successfully genotyped) typically exceeds 99.5% for high-quality samples. Where genotyping can fall short is in its completeness: it simply cannot see variants that are not on the chip. It is extremely accurate for what it tests, but it tests only a tiny fraction of the genome.

WGS Accuracy

At 30x coverage, WGS achieves over 99.5% sensitivity and 99.9% specificity for single nucleotide variants (SNVs) in high-confidence regions of the genome. However, accuracy drops in repetitive regions, regions with extreme GC content, and for certain variant types. Structural variant calling from short-read WGS remains imperfect - sensitivity for large deletions is approximately 80-90%, while complex rearrangements may be missed entirely. Long-read sequencing technologies (Pacific Biosciences, Oxford Nanopore) address some of these gaps but are not yet standard for clinical WGS.

The Accuracy Bottom Line

For the specific positions it tests, genotyping is marginally more accurate than WGS (because microarray probes are optimised for those exact positions). But WGS has vastly greater scope. Think of it this way: genotyping is like a sharpshooter who hits 700,000 specific targets with 99.9% accuracy. WGS is like a comprehensive sweep that covers the entire battlefield with 99.5% accuracy - it might miss a few things in tricky terrain, but it covers incomparably more ground.

What Each Test Reveals

Ancestry and Population Genetics

Both technologies provide excellent ancestry data. Genotyping arrays are specifically designed with ancestry-informative markers, and all major ancestry databases are built on genotyping data. WGS contains all the same ancestry markers (and more), but the additional data does not substantially improve ancestry resolution for most populations. For ancestry testing, genotyping is the clear value choice.

Health and Disease Risk

Genotyping covers common health-associated variants well, including those used in polygenic risk scores for conditions like type 2 diabetes, coronary artery disease, and breast cancer. WGS adds the ability to detect rare pathogenic variants in disease-associated genes that would not be on a genotyping chip. If you have a family history of a specific genetic condition or an undiagnosed condition with suspected genetic cause, WGS is more appropriate.

Pharmacogenomics

Genotyping arrays include the most clinically validated pharmacogenomic (PGx) markers - variants that affect how you metabolise drugs like warfarin, clopidogrel, codeine, and many antidepressants. For standard PGx profiling, genotyping is sufficient. WGS provides additional rare PGx variants and full gene sequences for complex genes like CYP2D6 (which has many structural variants that are difficult to genotype on arrays), making it more comprehensive for clinical pharmacogenomics.

Rare Variants and Novel Mutations

This is where WGS has an absolute advantage. Genotyping arrays can only detect variants that were known and included during chip design. They will miss any mutation that is rare (found in fewer than 1% of people), novel (never seen before), or family-specific. WGS reads everything, making it capable of detecting any variant in the genome. For rare disease diagnosis, this capability is essential - many disease-causing mutations are extremely rare or unique to individual families.

Data Size and Storage Considerations

The practical implications of data size are often overlooked when choosing a DNA test, but they matter - especially if you plan to store, share, or re-analyse your data.

• Genotyping raw data: Approximately 10-50 MB as a text file. Easily stored on any device, emailed, uploaded to third-party analysis tools, and backed up without concern. The file contains one line per SNP with the chromosome, position, and your genotype
• WGS raw data: Approximately 100-200 GB for raw sequencing reads (FASTQ format). The processed variant file (VCF) is 5-10 GB. The aligned reads file (BAM/CRAM) is 30-80 GB. Storing and transferring this data requires dedicated hard drive space, and re-analysing it requires bioinformatics expertise or access to specialised platforms

For most consumers, the compact genotyping data is far more practical. You can download it in seconds, upload it to tools like Promethease or GEDmatch, and store copies in multiple locations effortlessly. WGS data requires deliberate data management planning.

When to Choose SNP Genotyping

Genotyping is the right choice if your primary goals are any of the following:

• Ancestry discovery: You want to explore your ethnic composition, trace maternal and paternal haplogroups, and discover regional ancestral origins across India and South Asia
• Common trait insights: You are curious about genetic traits like lactose tolerance, caffeine sensitivity, earwax type, or taste perception
• Basic health screening: You want to check for common health-associated variants and carrier status for recessive conditions
• Pharmacogenomics: You want to understand how your genetics might affect your response to common medications
• Relative matching: You want to find genetic relatives through DNA matching databases
• Budget consciousness: You want the best value per insight - genotyping delivers an enormous amount of actionable information for Rs 5,000-15,000
• First-time DNA testing: You are new to genetic testing and want a comprehensive introduction without the complexity and cost of WGS

When to Choose Whole Genome Sequencing

WGS is the right choice if your needs fall into any of these categories:

• Rare disease investigation: You or a family member has an undiagnosed condition with suspected genetic cause, and targeted tests have been inconclusive
• Comprehensive health analysis: You want the most complete genetic profile possible, covering both common and rare variants across every gene
• Research participation: You are contributing to a genetics research study that requires full genome data
• Complex pharmacogenomics: You need full gene-level resolution for genes with complex structural variants (like CYP2D6) that arrays cannot fully resolve
• Future-proofing your data: You want a dataset that can be re-analysed as scientific knowledge grows, without needing to be retested. As new gene-disease associations are discovered, they can be looked up directly in your WGS data
• Structural variant screening: You need to detect large deletions, duplications, or other structural changes in your genome
• Clinical requirement: A genetic counsellor or physician has recommended WGS for a specific clinical question

Clinical vs Direct-to-Consumer DNA Testing

An important distinction that cuts across both genotyping and WGS is whether the test is offered as a clinical or direct-to-consumer (DTC) product.

Direct-to-Consumer (DTC) Testing

DTC tests (like Helixline Origins, 23andMe, AncestryDNA) are ordered directly by consumers without a physician. They provide ancestry, wellness, and trait information for educational purposes. DTC tests - whether genotyping or WGS-based - typically do not meet clinical laboratory standards (NABL/CAP accreditation in India) required for medical decision-making. Results should not be used for clinical diagnosis without independent confirmation through a clinical lab.

Clinical Testing

Clinical genetic tests are ordered by physicians or genetic counsellors, performed in accredited laboratories (NABL in India, CAP/CLIA in the US), and include variant interpretation by certified clinical geneticists. Clinical WGS is used for diagnosing rare genetic diseases, identifying cancer predisposition genes, and guiding treatment decisions. Clinical genotyping panels are used for carrier screening, pharmacogenomics in hospital settings, and newborn screening programmes.

Which Do You Need?

If you are healthy and curious about your ancestry, traits, and general wellness genetics, a DTC genotyping test like Helixline Origins is ideal. If you have a specific medical concern, a family history of genetic disease, or a physician's recommendation, pursue clinical testing through an accredited laboratory - and discuss with a genetic counsellor whether genotyping, WGS, or a targeted gene panel is most appropriate for your clinical question.

Future-Proofing Your Genetic Data

One of the strongest arguments for WGS is re-analysis potential. Scientific understanding of the genome is growing rapidly - new gene-disease associations, pharmacogenomic variants, and ancestry reference panels are published every month. With genotyping data, you are limited to the ~700,000 positions on your chip. If a newly discovered disease variant was not included on your array, you cannot check it without being retested. With WGS data, your entire genome is on file - any new discovery can be immediately looked up in your existing data.

However, this advantage has practical limits. Most newly discovered associations involve common variants that are likely already on modern genotyping arrays. And genotyping data can be imputed - statistical algorithms use patterns of linkage disequilibrium to infer your likely genotype at millions of positions not directly tested. Imputation effectively expands a 700,000-SNP dataset to 5-10 million variants with high accuracy for common SNPs, significantly closing the gap with WGS for many applications.

The pragmatic approach: start with genotyping to get immediate value at low cost, and pursue WGS later if a clinical need or strong personal interest justifies the additional investment.

Helixline's Approach: Both Technologies, South Asian Optimised

Helixline offers both DNA testing technologies, each optimised specifically for South Asian genetics:

• Helixline Origins (Rs 6,999): SNP genotyping on the Illumina Global Screening Array with custom South Asian content. Includes ancestry composition across 75+ regions (the most granular South Asian ancestry breakdown available), maternal and paternal haplogroups, genetic traits, wellness insights, and pharmacogenomics. Ideal for ancestry exploration, trait discovery, and general wellness screening
• Helixline Genome (Rs 17,999): 30x whole genome sequencing with comprehensive variant analysis. Includes everything in Origins plus rare variant detection, structural variant screening, complete mitochondrial sequencing, and a dataset that can be re-analysed as new discoveries emerge. Ideal for those who want the most complete genetic picture or have specific health questions that genotyping cannot address

What makes both Helixline products different from international competitors is the South Asian reference panel. Most global DNA testing companies built their algorithms on predominantly European reference data, leading to less accurate ancestry resolution and risk scoring for Indian users. Helixline's algorithms are trained on South Asian population data, delivering more meaningful results for Indians - whether you choose genotyping or WGS.

Frequently Asked Questions

Is whole genome sequencing better than SNP genotyping?

WGS provides more comprehensive data by reading all 3.2 billion base pairs, compared to the 600,000-700,000 positions checked by SNP genotyping. However, "better" depends on your goals. For ancestry analysis, common trait prediction, carrier screening, and pharmacogenomics, SNP genotyping is highly effective and costs a fraction of WGS. WGS is superior for detecting rare variants, novel mutations, and structural variants. For most consumer DNA testing purposes, SNP genotyping offers the best balance of information and affordability.

How much does whole genome sequencing cost in India?

In India, whole genome sequencing typically costs between Rs 15,000 and Rs 50,000 depending on coverage depth (15x vs 30x), the laboratory, and whether clinical interpretation is included. Clinical-grade 30x WGS from NABL-accredited labs tends to be at the higher end. SNP genotyping tests cost Rs 5,000-15,000. Helixline offers genotyping ancestry kits starting at Rs 6,999 (Origins) and whole genome sequencing via the Genome tier at Rs 17,999.

Can SNP genotyping detect rare genetic diseases?

SNP genotyping can detect some known disease-associated variants that have been specifically included on the microarray chip, including carrier status for common recessive conditions like cystic fibrosis, sickle cell disease, and beta-thalassemia. However, it cannot detect rare or novel mutations, de novo mutations, or family-specific variants that are not pre-loaded on the chip. If you suspect a rare genetic condition based on family history or clinical symptoms, whole genome sequencing or targeted gene panel testing ordered through a clinical geneticist is more appropriate.

What is 30x coverage in whole genome sequencing?

Coverage depth (often written as 30x) refers to how many times, on average, each base pair in the genome is read during sequencing. At 30x coverage, every position is read approximately 30 times. This redundancy is essential for accuracy - reading each position multiple times allows sequencing software to distinguish true genetic variants from random errors. Clinical-grade WGS typically uses 30x coverage, achieving over 99.5% accuracy for single nucleotide variants. Lower coverage (like 15x or 0.4x) is cheaper but less reliable for detecting heterozygous variants.

Should I choose genotyping or sequencing for ancestry testing?

For ancestry testing, SNP genotyping is the recommended choice. Ancestry analysis relies on comparing your DNA against reference populations at hundreds of thousands of known ancestry-informative markers. Genotyping arrays are specifically designed to include these markers and are optimised for population differentiation. The major ancestry databases are built on genotyping data, ensuring compatibility for relative matching. WGS will also work for ancestry, but you would be paying significantly more for data that does not materially improve ancestry results. Helixline's Origins kit uses SNP genotyping optimised for South Asian genetics with 75+ regional ancestry categories.

Can I upgrade from genotyping to whole genome sequencing later?

Yes, you can take a WGS test at any time after having done a genotyping test - they are independent tests. However, genotyping data cannot be "upgraded" to WGS data computationally; they are fundamentally different technologies. Your genotyping data remains valuable even after WGS because it can be used with imputation algorithms to infer millions of additional variants, and it is compatible with the largest relative-matching databases. Many people start with genotyping for ancestry and basic health insights, then pursue WGS later if they need comprehensive genetic analysis.

How long does each type of DNA test take to get results?

SNP genotyping typically delivers results in 3-5 weeks from when the laboratory receives your sample. The lab process itself takes about 3-5 days, with the remainder being shipping time and bioinformatics analysis. Whole genome sequencing takes longer - typically 6-10 weeks - because the sequencing run takes several days and computational analysis of 100+ GB of raw data requires significantly more processing time. At Helixline, Origins (genotyping) results are delivered in approximately 4 weeks, while Genome (WGS) results take approximately 8 weeks.

Conclusion

The choice between whole genome sequencing and SNP genotyping is not about which technology is objectively superior - it is about which technology is right for your specific goals, budget, and circumstances. SNP genotyping is one of the most remarkable value propositions in modern science: for under Rs 7,000, you get precise ancestry composition, haplogroup assignments, health markers, pharmacogenomic insights, and trait predictions based on 700,000 carefully selected data points. Whole genome sequencing is the more powerful and comprehensive tool, reading every base pair in your genome, but it costs more, takes longer, generates vastly more data, and much of that additional data is relevant only for specialised clinical or research applications.

For the vast majority of people exploring DNA testing for the first time - curious about their ancestral roots, interested in wellness genetics, or wanting to understand how their body might respond to medications - SNP genotyping is the clear starting point. It delivers outstanding value and actionable insights without the cost and complexity of WGS.

For those with specific clinical questions, a family history of rare genetic conditions, or a desire for the most complete genetic dataset possible, whole genome sequencing is the investment worth making. And with Helixline offering both options optimised for South Asian genetics, you do not have to compromise on relevance regardless of which technology you choose.

Ready to explore your DNA? Visit the Helixline shop to compare Origins (genotyping) and Genome (WGS) kits and find the right test for your goals.